PRINS RICHARD K 4
4 · IGC Pharma, Inc. · Filed Oct 22, 2025
Insider Transaction Report
Form 4
PRINS RICHARD K
Director
Transactions
- Award
Options
2025-10-17+750,000→ 750,000 totalExp: 2038-03-31→ Common Stock (750,000 underlying)
Footnotes (1)
- [F1]The Reporting Person was granted 750,000 options exercisable at $0.35, equally vesting over the next three years starting on March 31st, 2026.